欢迎来到 Worthington中国区代理商/公司/官网
全国咨询热线: 15172431432
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18771997407

传真:18372041646

邮箱:sales@amyjet.com

新闻中心
艾美捷官网上传-2.5:1.jpgexocell.jpg

艾美捷科技代理Cell Culture Technologies品牌培养基产品品牌。

Cell Culture Technologies(CCT)是一家瑞士生物技术公司,成立于1992年,创始人为Ferruccio Messi博士;Cell Culture Technologies专注于细胞培养技术领域,拥有深厚的专业知识和技术积累,致力于开发和应用创新的细胞培养解决方案。经典产品:如Hektor G培养基(用于293细胞的日常维护与低温保存)、ChoMaster HTS培养基(用于CHO细胞的低温保存和稳定转染)、InVitrus培养基(用于肾源细胞的常规维护和低温保存)等。这些产品广泛应用于生物制药、细胞疗法、疫苗生产等领域。产品分类包括:

(1)最小培养环境中的细胞培养与冷冻保存:能够在极小的培养环境中对人类和动物细胞系进行培养和冷冻保存,保持细胞的活性和稳定性。

(2)化学定义的无蛋白和无肽培养基:开发了能够在这种培养基中生长的动物细胞生物工艺,为细胞培养提供了更为纯净和可控的环境。

(3)全合成细胞培养基的开发与大规模生产:成功开发出全合成细胞培养基,并实现了大规模生产,满足了生物制药、细胞疗法等领域对高质量细胞培养基的需求。



<<<<<< " data-original="http://worthington.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Cell Culture Technologies品牌培养基产品">
艾美捷科技代理Cell Culture Technologies品牌培养基产品
...
阅读详情
Innovative Research of America.jpg

Innovative Research of America(IRA) 是一家致力研发于药物定量定时缓释系统的专业化公司,又称Matrix-Driven Delivery (MDD) 给药系统。该给药系统由一个可生物吸收的基质组成,含有定量可控的活性给药成分,可以以设定的剂量在一定时间范围内进行给药。

 

Since it is not easy to administer drugs and hormones orally to research animals, several delivery methods have been devised as alternatives.  However, most scientists continue to labor with unreliable injectables to conduct their research.

 

Matrix-Driven Delivery (MDD) Pellet(MDD片剂)的优势

Saves time

Ready-to-implant

Insures controlled product release over time

Avoids "peak and valley" effects

Guarantees consistent product preparation

Extends product life against spontaneous breakdown

Extends product life against host-related breakdown

Minimizes experimental variables

Insures safety of the experimenter

Reduces neurophysiological trauma to animal/no excessive handling

Generates more meaningful and reproducible results

Superior to conventional delivery methods

Enhances experimental efficiency

Frees valuable time for creative research

Saves money

 

Innovative Research of America的主要产品包括:

ANTIBIOTICS

ANTI-INFLAMMATORY AGENTS

ANTI-NEOPLASTICS

CATECHOLAMINES & RELATED PRODUCTS

CORTICOIDS & DIURETICS

ESTROGENS & ANTI-ESTROGENS

FATTY ACIDS

MISCELLANEOUS PRODUCTS

NUCLEOTIDE RELATED PRODUCTS

PLACEBO

PROGESTINS

PROSTAGLANDINS

THYROIDS

VITAMINS

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

" data-original="http://worthington.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Innovative Research of America">
Innovative Research of America
...
阅读详情
BioGenex Logo.jpg

艾美捷科技代理BioGenex品牌产品。

Biogenex位于美国旧金山,是抗原修复的发明者,是致力于研发生产准确、可靠、可重复性的高效检测方法的自动化和标准化的先驱。BioGenex拥有全面的免疫组化全自动处理系统,包括i1000抗原修复系统、i6000自动染色仪、iVISION数码成像分析系统等,具有检测诊断的高度一致性,为科研和临床诊治提供高质量的参考依据。Biogenx i 系列免疫组化全自动处理系统是使您的科研和临床病理诊断国际化的最佳途径。

 

BioGenex is a global market leader and an innovator in providing customer-centric molecular pathology solutions and complete walk-away automation of cell and tissue staining. We develop, manufacture and market automated slide-based staining instruments and offer a broad range of histology products for immunohistochemistry (IHC), in-situ hybridization (ISH), miRNA, in situ PCR.

 

BioGenex的主要产品包括:

(1)IHC

Automation

Primary Antibodies

Antigen Retrieval & Dewax

Detection Systems

Controls

Ancillaries

(2)ISH/CISH

Automation

ISH/CISH Probes

Nucleic Retrieval & Dewax

Detection Systems

Ancillaries

(3)FISH

eFISH Automation

eFISH Probes

Nucleic Retrieval & Dewax

eFISH Visualization Kits

eFISH Ancillaries

(4)miRNA

miRNA Automation

miRNA Probes & Controls

Nucleic Retrieval & Dewax

Detection Systems

Ancillaries

(5)Multiplexing & Double Staining

Automation

Antibody Cocktails

Multiplexing

Antigen Retrieval & Dewax

Detection Systems

Ancillaries

(6)Special Stains

Automation

Special Stains

Ancillaries

(7)In Situ PCR

(8)1IF

" data-original="http://worthington.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理BioGenex品牌产品">
艾美捷科技代理BioGenex品牌产品
...
阅读详情
Dendritics.jpg

Dendritics公司主要关注人类树突状细胞,希望找到能够促使CD34+造血前体细胞转化为树突状细胞(在GM-CSF和TNF-alpha存在的情况下)的细胞因子。在1992-2005年间,大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

 

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

 

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

 

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

<<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

" data-original="http://worthington.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Dendritics">
Dendritics
...
阅读详情

Copyright © 2026 Powered by Worthington中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap